SIRT5 and triple-negative breast carcinoma: We have shown that in triple-negative breast cancer cells, SIRT5 inhibition or silencing decreased the association between GLS1 and SIRT5 while increasing glutamine metabolism, ammonia production and ammonia-induced autophagy [26].